Drug Type Small molecule drug |
Synonyms- |
Action antagonists, agonists |
Mechanism mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Belgium | 24 Jul 2025 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Czechia | 24 Jul 2025 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Netherlands | 24 Jul 2025 | |
Locally Advanced Malignant Solid Neoplasm | Phase 1 | Spain | 24 Jul 2025 | |
Asthma | Phase 1 | - | - | |
Asthma | Phase 1 | - | - | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | - | - | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | - | - |